Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced the authorization of 20 ZYN nicotine pouch products through its premarket tobacco product application (PMTA) pathway. This landmark …
FDA Grants First Marketing Authorizations for ZYN Nicotine Pouch Products Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture (USDA) is now accepting applications for the prestigious USDA 1890 National Scholars Program, a scholarship initiative aimed at fostering the next generation of …
USDA Opens Applications for 1890 National Scholars Program Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently released a draft guidance in collaboration with the Office for Human Research Protections, outlining recommendations for including tissue biopsies in …
FDA Issues Draft Guidance on Tissue Biopsies in Clinical Trials Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC), alongside the U.S. Department of Agriculture (USDA) and the Department of the Interior (DOI), has released the country’s first National …
U.S. Agencies Unveil National One Health Framework to Combat Zoonotic Diseases Read More
RADNOR, PA — Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for a Phase 2 clinical trial …
Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating Sleep Apnea and Hypertension Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced that the U.S. Food and Drug Administration (FDA) has accepted an updated protocol for the company’s pivotal Phase 3 Alzheimer’s (AD) …
FDA Accepts Revised Protocol for Annovis Bio’s Phase 3 Alzheimer’s Study Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration isn’t just making a suggestion—it’s drawing a line in the sand. Last week, the FDA proposed a hard-hitting rule to establish standardized …
FDA Takes Bold Stand to Protect Consumers with Standardized Asbestos Testing in Talc-Based Cosmetics Read More
WASHINGTON, D.C. — A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a revolutionary therapy aimed at tackling the devastating condition known as steroid-refractory …
FDA Approves Groundbreaking Cell Therapy for Life-Threatening Pediatric Disease Read More WASHINGTON, D.C. — The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and Drug Administration (FDA) has approved a drug …
FDA Approves Zepbound in Landmark Move to Battle Obstructive Sleep Apnea Read More WASHINGTON, D.C. — A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially approved Symvess, the first acellular tissue-engineered vessel designed to repair damaged …
FDA Approves First-Ever Tissue-Engineered Vessel for Vascular Trauma Read More